D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach

R E Williams1, H Major, E A Lock

  • 1Department of Drug Metabolism and Pharmacokinetics, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK.

Toxicology
|December 15, 2004
PubMed